Normal view MARC view ISBD view

Spoilage characteristics of ground beef with added lactic acid bacteria and rosemary oleoresin packaged in a modified-atmosphere package and displayed at abusive temperatures. [electronic resource]

By:

Parks, A R Hoyle

Contributor(s):

Producer: 20121025Description: 2054-60 p. digitalISSN:

1525-3163

Subject(s):

Online resources:

Available from publisher's website

In: Journal of animal science vol. 90

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

81 Metabolic syndrome: definition, pathophysiology, and mechanisms.
by Miranda, Phillippa J
82 The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone.
by DeFronzo, Ralph A
83 Metabolic syndrome: evaluation of pathological and therapeutic outcomes.
by Miranda, Phillippa J
84 Hypoadiponectinemia is closely associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.
by Kashyap, Sangeeta R
85 Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
by Tripathy, Devjit
86 Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
by Armato, John P
87 The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes.
by Abdul-Ghani, Muhammad A
88 Decreased basal hepatic glucose uptake in impaired fasting glucose.
by Alatrach, Mariam
89 Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
by Bajaj, Mandeep
90 Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.
by Abdul-Ghani, Muhammad A
91 Insulin reduces plasma arginase activity in type 2 diabetic patients.
by Kashyap, Sangeeta R
92 Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.
by Gaggini, Melania
93 Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
by Miyazaki, Yoshinori
94 Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus.
by Triplitt, C
95 Thiazolidinediones improve beta-cell function in type 2 diabetic patients.
by Gastaldelli, Amalia
96 Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
by Schneider, Christian A
97 beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
by Ferrannini, Ele
98 Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.
by Pratipanawatr, Thongchai
99 Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications.
by Abdul-Ghani, Muhammad A
100 Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.
by Alatrach, Mariam